Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
BRIEF-Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million Aug 06 (Reuters) - Sonoma Pharmaceuticals Q1 EBITDA USD 100 thousand.
- Q1 gross profit USD 2.6 million
- Q1 revenue USD 6.4 million
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing